| dc.contributor.author |
Khan B A |
en_US |
| dc.date.accessioned |
2017-01-30T08:15:50Z |
|
| dc.date.available |
2017-01-30T08:15:50Z |
|
| dc.identifier.uri |
http://hdl.handle.net/123456789/175152 |
|
| dc.identifier.uri |
http://localhost:8080/xmlui/handle/1/59 |
|
| dc.description.abstract |
Searle examined the loans involved in the flotation of new shares. This particular case examines a local company which had recently acquired a multinational status and then wished to make a private placement at a substantial premium. The case looks at the role of the regulatory authorities, the mechanisms of capital restructuring, and the implication for shareholders. |
en_US |
| dc.publisher |
YES |
en_US |
| dc.subject |
Pharmaceuticals |
|
| dc.subject.classification |
Finance |
en_US |
| dc.subject.other |
Capital structure, pharmaceuticals, valuation, stock issues, government regulations |
en_US |
| dc.title |
SEARLE PAKISTAN (PRIVATE) LIMITED |
en_US |
| dc.type |
02-414-95-1 |
en_US |
| dc.location |
Case Research Centre |
en_US |